Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

door Richardson, Paul, Mitsiades, Constantine, Laubach, Jacob, Schlossman, Robert, Ghobrial, Irene, Hideshima, Teru, Munshi, Nikhil, Anderson, Kenneth
Gepubliceerd in 2010

The Treatment of Multiple Myeloma Patients Not Eligible for Asct

door Richardson, Paul, Laubach, Jacob, Mahindra, Anuj, Mitsiades, Constantine, Schlossman, Robert, Ghobrial, Irene, Hideshima, Teru, Raje, Noopur, Munshi, Nikhil, Anderson., Kenneth
Gepubliceerd in 2010

Bortezomib in the management of multiple myeloma

door Laubach, Jacob P, Mitsiades, Constantine S, Hideshima, Teru, Schlossman, Robert, Chauhan, Dharminder, Munshi, Nikhil, Ghobrial, Irene, Carreau, Nicole, Anderson, Kenneth C, Richardson, Paul G
Gepubliceerd in 2009

The Medical Research Council Myeloma IX trial: the impact on treatment paradigms*

door Richardson, Paul G, Laubach, Jacob P, Schlossman, Robert L, Ghobrial, Irene M, Mitsiades, Constantine S, Rosenblatt, Jacalyn, Mahindra, Anuj, Raje, Noopur, Munshi, Nikhil, Anderson, Kenneth C
Gepubliceerd in 2012

Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor

door Bellucci, Roberto, Alyea, Edwin P., Chiaretti, Sabina, Wu, Catherine J., Zorn, Emmanuel, Weller, Edie, Wu, Bingyan, Canning, Christine, Schlossman, Robert, Munshi, Nikhil C., Anderson, Kenneth C., Ritz, Jerome
Gepubliceerd in 2005

Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function

door McMillin, Douglas W., Delmore, Jake, Negri, Joseph M., Vanneman, Matthew, Koyama, Shohei, Schlossman, Robert L., Munshi, Nikhil C., Laubach, Jacob, Richardson, Paul G., Dranoff, Glenn, Anderson, Kenneth C., Mitsiades, Constantine S.
Gepubliceerd in 2012

Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study

door Rosovsky, Rachel, Hong, Fangxin, Tocco, Deanna, Connell, Brendan, Mitsiades, Constantine, Schlossman, Robert, Ghobrial, Irene, Lockridge, Leslie, Warren, Diane, Bradwin, Gary, Doyle, Mary, Munshi, Nikhil, Soiffer, Robert J., Anderson, Kenneth C., Weller, Edie, Richardson, Paul
Gepubliceerd in 2012

Molecular and cellular effects of multi-targeted CDK inhibition in myeloma: Biological and clinical implications

door McMillin, Douglas W., Delmore, Jake, Negri, Joseph, Buon, Leutz, Jacobs, Hannah M., Laubach, Jacob, Jakubikova, Jana, Ooi, Melissa, Hayden, Patrick, Schlossman, Robert, Munshi, Nikhil C., Lengauer, Christoph, Richardson, Paul G., Anderson, Kenneth C., Mitsiades, Constantine S.
Gepubliceerd in 2011

Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation

door Weinstock, Mathew, Aljawai, Yosra, Morgan, Elizabeth A., Laubach, Jacob, Gannon, Muriel, Roccaro, Aldo M., Varga, Cindy, Mitsiades, Constantine S., Paba-Prada, Claudia, Schlossman, Robert, Munshi, Nikhil, Anderson, Kenneth C., Richardson, Paul P., Weller, Edie, Ghobrial, Irene M.
Gepubliceerd in Br J Haematol (2015)

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

door Gribben, John G., Zahrieh, David, Stephans, Katherine, Bartlett-Pandite, Lini, Alyea, Edwin P., Fisher, David C., Freedman, Arnold S., Mauch, Peter, Schlossman, Robert, Sequist, Lecia V., Soiffer, Robert J., Marshall, Blossom, Neuberg, Donna, Ritz, Jerome, Nadler, Lee M.
Gepubliceerd in 2005

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anti-cancer drug activity

door McMillin, Douglas W., Delmore, Jake, Weisberg, Ellen, Negri, Joseph M., Geer, D. Corey, Klippel, Steffen, Mitsiades, Nicholas, Schlossman, Robert L., Munshi, Nikhil C., Kung, Andrew L., Griffin, James D., Richardson, Paul G., Anderson, Kenneth C., Mitsiades, Constantine S.
Gepubliceerd in 2010

Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling

door Ho, Matthew, Chen, Tianzeng, Liu, Jiye, Dowling, Paul, Hideshima, Teru, Zhang, Li, Morelli, Eugenio, Camci-Unal, Gulden, Wu, Xinchen, Tai, Yu-Tzu, Wen, Kenneth, Samur, Mehmet, Schlossman, Robert L., Mazitschek, Ralph, Kavanagh, Emma L., Lindsay, Sinéad, Harada, Takeshi, McCann, Amanda, Anderson, Kenneth C., O’Gorman, Peter, Bianchi, Giada
Gepubliceerd in Leukemia (2019)

Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma

door Richardson, Paul G., Weller, Edie, Jagannath, Sundar, Avigan, David E., Alsina, Melissa, Schlossman, Robert L., Mazumder, Amitabha, Munshi, Nikhil C., Ghobrial, Irene M., Doss, Deborah, Warren, Diane L., Lunde, Laura E., McKenney, Mary, Delaney, Carol, Mitsiades, Constantine S., Hideshima, Teru, Dalton, William, Knight, Robert, Esseltine, Dixie-Lee, Anderson, Kenneth C.
Gepubliceerd in 2009

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

door Richardson, Paul G., Siegel, David, Baz, Rachid, Kelley, Susan L., Munshi, Nikhil C., Laubach, Jacob, Sullivan, Daniel, Alsina, Melissa, Schlossman, Robert, Ghobrial, Irene M., Doss, Deborah, Loughney, Nora, McBride, Laura, Bilotti, Elizabeth, Anand, Palka, Nardelli, Lisa, Wear, Sandra, Larkins, Gail, Chen, Min, Zaki, Mohamad H., Jacques, Christian, Anderson, Kenneth C.
Gepubliceerd in 2013

Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment

door Richardson, Paul G., Hungria, Vânia T. M., Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios Athanasios, Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Nakorn, Thanyaphong Na, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, Binlich, Florence, San-Miguel, Jesús F.
Gepubliceerd in Blood (2016)

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy

door Richardson, Paul G., Xie, Wanling, Mitsiades, Constantine, Chanan-Khan, Asher A., Lonial, Sagar, Hassoun, Hani, Avigan, David E., Oaklander, Anne Louise, Kuter, David J., Wen, Patrick Y., Kesari, Santosh, Briemberg, Hannah R., Schlossman, Robert L., Munshi, Nikhil C., Heffner, L. Thompson, Doss, Deborah, Esseltine, Dixie-Lee, Weller, Edie, Anderson, Kenneth C., Amato, Anthony A.
Gepubliceerd in 2009

Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial

door Jakubowiak, Andrzej J., Griffith, Kent A., Reece, Donna E., Hofmeister, Craig C., Lonial, Sagar, Zimmerman, Todd M., Campagnaro, Erica L., Schlossman, Robert L., Laubach, Jacob P., Raje, Noopur S., Anderson, Tara, Mietzel, Melissa A., Harvey, Colleen K., Wear, Sandra M., Barrickman, Jennifer C., Tendler, Craig L., Esseltine, Dixie-Lee, Kelley, Susan L., Kaminski, Mark S., Anderson, Kenneth C., Richardson, Paul G.
Gepubliceerd in 2011

A Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone in Transplant-Ineligible Multiple Myeloma

door O’Donnell, Elizabeth K., Laubach, Jacob P., Yee, Andrew J., Chen, Tianqi, Huff, Carol Ann, Basile, Frank G., Wade, Philip M., Paba-Prada, Claudia E., Ghobrial, Irene M., Schlossman, Robert L., Burke, Jill N., Harrington, Cynthia C., Lively, Kathleen J., Lyons, Hannah F., Munshi, Nikhil C., Anderson, Kenneth C., Trippa, Lorenzo, Richardson, Paul G., Raje, Noopur S.
Gepubliceerd in Br J Haematol (2018)

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

door Richardson, Paul G., Blood, Emily, Mitsiades, Constantine S., Jagannath, Sundar, Zeldenrust, Steven R., Alsina, Melissa, Schlossman, Robert L., Rajkumar, S. Vincent, Desikan, K. Raman, Hideshima, Teru, Munshi, Nikhil C., Kelly-Colson, Kathleen, Doss, Deborah, McKenney, Mary L., Gorelik, Svetlana, Warren, Diane, Freeman, Andrea, Rich, Rebecca, Wu, Anfang, Olesnyckyj, Marta, Wride, Kenton, Dalton, William S., Zeldis, Jerome, Knight, Robert, Weller, Edie, Anderson, Kenneth C.
Gepubliceerd in 2006

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

door Richardson, Paul G., Weller, Edie, Lonial, Sagar, Jakubowiak, Andrzej J., Jagannath, Sundar, Raje, Noopur S., Avigan, David E., Xie, Wanling, Ghobrial, Irene M., Schlossman, Robert L., Mazumder, Amitabha, Munshi, Nikhil C., Vesole, David H., Joyce, Robin, Kaufman, Jonathan L., Doss, Deborah, Warren, Diane L., Lunde, Laura E., Kaster, Sarah, DeLaney, Carol, Hideshima, Teru, Mitsiades, Constantine S., Knight, Robert, Esseltine, Dixie-Lee, Anderson, Kenneth C.
Gepubliceerd in 2010